Skip to main content
Journal of Clinical Research in Pediatric Endocrinology logoLink to Journal of Clinical Research in Pediatric Endocrinology
. 2012 Jun 9;4(2):51–60. doi: 10.4274/Jcrpe.569

Fetal and Neonatal Endocrine Disruptors

Tolga Ünüvar 1,, Atilla Büyükgebiz 2
PMCID: PMC3386773  PMID: 22672860

Abstract

Endocrine disruptors are substances commonly encountered in every setting and condition in the modern world. It is virtually impossible to avoid the contact with these chemical compounds in our daily life. Molecules defined as endocrine disruptors constitute an extremely heterogeneous group and include synthetic chemicals used as industrial solvents/lubricants and their by-products. Natural chemicals found in human and animal food (phytoestrogens) also act as endocrine disruptors. Different from adults, children are not exposed only to chemical toxins in the environment but may also be exposed during their intrauterine life. Hundreds of toxic substances, which include neuro-immune and endocrine toxic chemical components that may influence the critical steps of hormonal, neurological and immunological development, may affect the fetus via the placental cord and these substances may be excreted in the meconium. Children and especially newborns are more sensitive to environmental toxins compared to adults. Metabolic pathways are immature, especially in the first months of life. The ability of the newborn to metabolize, detoxify and eliminate many toxins is different from that of the adults. Although exposures occur during fetal or neonatal period, their effects may sometimes be observed in later years. Further studies are needed to clarify the effects of these substances on the endocrine system and to provide evidence for preventive measures.

Conflict of interest:None declared.

Keywords: endocrine disruptors, fetal, neonatal

INTRODUCTION

Endocrine disruptors (xenohormones) are exogenous substances or compounds that cause adverse health effects in the organism by disrupting the endocrine functions (1,2,3).Endocrine disruptions mostly occur on the basis of genetic predisposition. Natural or synthetic chemical endocrine disrupting substances that we are surrounded with and are exposed to in the modern world lead to clinical disorders by intervening with hormonal physiology (4). At first, endocrine disruptors were thought to act only via nuclear hormone receptors such as estrogen, androgen, progesterone, thyroid and retinoid receptors. However, recent studies have shown that the mechanism of action of endocrine disruptors is not that simple. Endocrine disruptors are thought to exert effects on endocrine and reproductive systems through nuclear receptors, non-nuclear steroid hormone receptors (membrane estrogen receptors), non-steroid receptors (neurotransmitter receptors such as serotonin, dopamine, norepinephrine receptors), orphan receptors (aryl hydrocarbon receptor), enzymatic pathways involving steroid biosynthesis and/or metabolism, and numerous other mechanisms (3). Endocrine disruptors are also known as endocrine modulators, hormone active agents, endocrine active agents, endocrine toxins or xenohormones (5,6). Molecules defined as endocrine disruptors constitute an extremely heterogeneous group and include synthetic chemicals used as industrial solvents/lubricants and their by-products (polychlorinated biphenyls, polybrominated biphenyls, dioxins), plastics (bisphenol A), plasticisers (phthalates), pesticides [methoxychlor, chlorphyrifos, dichlorodiphenyl-trichloroethane (DDT)], fungicides (vinclozolin) and pharmaceutical agents (diethylstilbestrol) (3). Natural chemicals found in human and animal food (phytoestrogens such as genistein, coumestrol) also act as endocrine disruptors (5,7) (Table 1). Different from adults, infants and children are not exposed only to chemical toxins in the environment but may also be exposed indirectly during their intrauterine life. Hundreds of toxic substances may affect the fetus via the placental cord and these substances may be excreted via the meconium. These include countless number of neuro-immune and endocrine toxic chemical components that may influence the critical steps of hormonal, neurological and immunological development. It has been demonstrated in animal and human studies that affected offsprings are not only born with congenital abnormalities but may also suffer from several health and behavioral problems throughout their lifespan (8). Measurement of endocrine disruptor levels in the umbilical cord blood of newborns is one of the several methods to determine intrauterine fetal exposure to chemical substances. In a study conducted in the US by the Environmental Working Group (EWG), 413 toxic substances were sought in the umbilical cord blood of 10 newborns, with positive results for 287 of these substances (Table 2). In the same study, many endocrine-disrupting chemical compounds including pharmaceutical agents, illegal drugs, heavy metals and pesticides were also detected in the meconium samples from the newborns. Children and especially newborns are more sensitive to environmental toxins compared to adults. Metabolic pathways in infants are immature, especially in the first months of life. Newborns differ from adults in their ability to metabolize, detoxify and eliminate many toxins. It has been demonstrated in various studies that newborns are affected from chemical toxins to a greater degree than adults (9). Although exposures have occurred during fetal life or during the neonatal period, the effect of these exposures may sometimes not be observed for many years. For these reasons, some of the states caused by endocrine disruptors are among examples of adult disease states of fetal origin (10). Owing to the fact that endocrine disruptors have low water solubility and high lipid solubility, they accumulate in fatty tissues. Thus, their long-term effects may be observed in later years.

Table 1. The most common chemicals found in the environment ([ref:5]5[/ref],[ref:7]7[/ref]).

graphic file with name JCRPE-4-51-g1.jpg

Table 2. Endocrine disruptors detected in umbilical cord blood ([ref:8]8[/ref]).

graphic file with name JCRPE-4-51-g2.jpg

Effects of Endocrine Disruptors on Growth

Intrauterine exposure to endocrine disruptors has been associated with low birth weight, low height and low head circumference in the newborns. The main chemical compounds that affect growth in infancy are the chlorinated pesticide metabolites dichlorodiphenyldichloroethylene (DDE), organophosphate pesticides and polycyclic aromatic hydrocarbons (PAH). Growth retardation has been noted in a 5-year follow-up of children after prenatal exposure to dioxins polychlorinated dioxins and furans (PCDD/PCDFs) (11).

Polycyclic Aromatic Hydrocarbons

These substances are found in combustion by-products associated with smoking, vehicle exhaust, factory chimneys, forest fires, and jet motors. It is well known that maternal smoking during pregnancy is associated with low birth weight (12). It has also been shown that air pollution in the cities is another source of PAH and that it is associated with low birth weight, reduced height and low head circumference in the newborn (13,14).

Organophosphate Pesticides

It has been reported that intrauterine exposure to these substances is associated with height, weight and head circumference retardation in the newborns (15). Moreover, severe mental retardation, as well as abnormalities pertaining to the development of the brain, eyes, ears, teeth, heart, feet, breast and sexual organs (undescended testicles, microphallus, labial fusion) have been observed in affected infants at birth (16).

Effects of Endocrine Disruptors on the Development of the Immune System

Some lead-containing endocrine-disrupting compounds have been shown to result in domination of T helper cells (TH2) in the fetal immune system, which in turn leads to an increased predisposition to asthma and allergies in newborns and infants (17). It has been shown that intrauterine exposure to dioxin leads to the development of autoimmunity in animals (18). Since most of the developmental activity in the immune system occurs in the first trimester of pregnancy, exposure to foreign substances during this period may have a greater impact. Depending on the time of impact, exposure to PAH may lead to imbalances in the immune system such as decrease in T cells, increase in B cells, and elevation in IgE levels (19). It has been found in animal studies that intrauterine exposure to polychlorinated biphenyls (PCBs) results in atrophy of the thymus. Respiratory tract infections have been noted to be more common and to show a tendency to recur more frequently in children exposed to PCB and DDE during the prenatal period as compared to children who are not affected (20,21). In addition to increased tendency for infections in infants affected by endocrine disruptors, immune response is also weakened. It was demonstrated in a Dutch study that insufficient amounts of antibodies were formed following measles-mumps-rubella vaccine in children exposed to PCB (21).

Effects of Endocrine Disruptors on the Nervous System

As the blood-brain barrier has not yet completed its development during the fetal development of the nervous system, the fetus is more sensitive to all neurotoxins.

Mercury: High levels of mercury have been found in hair samples of infants born to women who have consumed high amounts of seafood during their pregnancy. These children may experience cognitive and behavioral disorders in later life (22).

Lead: Reduction in memory and problem-solving abilities have been noted in rats with prenatal lead exposure (23). Deficits in mental abilities have been reported in a 24-month follow-up of children with intrauterine exposure to high amounts of lead from maternal bone stores (24).

Polychlorinated biphenyls: Long-term neurological deficits and persistent behavioral problems have been reported in rats with neonatal PCB exposure. Also, intellectual functions have been found to be affected in infants whose mothers had consumed fish exposed to PCB during pregnancy (25). Reduction in comprehension and cognitive functions have been noted even in children born as late as six years after the incident in which their mothers were affected and these children were also observed to have significantly more behavioral and activity problems compared to the control group (26).

Organophosphate pesticides: Children with intrauterine exposure to organophosphate pesticides have been found to exhibit abnormal reflexes at the time of birth (27). These children were also noted to have poor short-term memory, slow response times as well as impaired mental development (28).

Effects of Endocrine Disruptors on the Urogenital System

Sex steroids, and especially androgens are very important for normal intrauterine sexual development (29). Sexual differentiation of a male fetus is androgen-dependent (estrogen is also effective in a small degree). However, sexual differentiation of a female fetus is often independent of androgens and estrogens. Therefore, sexual development disorders related to endocrine disruptors, which excellently mimic estrogens and/or block androgens, lead to different clinical presentations in girls and boys (30) (Table 3).

Table 3. The potential effects of endocrine disruptors on the urogenital system.

graphic file with name JCRPE-4-51-g3.jpg

The Male Urogenital System

A weak association has been found between maternal serum concentrations of PCB, dichlorodiphenyltrichloroethane (DDT) and DDE (primary DDT metabolites) and occurrence of undescended testicles and hypospadias in infants born to these mothers (31,32). On the other hand, significant relationships between development of hypospadias or undescended testicle and consanguineous marriages or pesticide exposure have been reported (33). It has also been shown that 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) exposure of male rats during intrauterine and lactation periods leads to sexual differentiation in the brain and sexual behavior changes (34,35). Estrogen and testosterone levels in umbilical cord blood of newborns whose mothers were exposed to high levels of PCDD and PCDF were found to be lower compared to the control group (36). In a study conducted on Taiwanese boys exposed to intrauterine PCB and PCDF, a reduction in serum testosterone levels together with an increase in serum follicle-stimulating hormone (FSH) and estradiol levels during puberty were reported (37). It has been shown in experimental studies that phthalates have antiandrogenic and mild estrogenic effects and may cause ambiguous genitalia in male infants (38). The effects of certain specific endocrine disruptors on male urogenital system are presented in Table 4.As the half-life of organochlorines is very long (years or even decades), intrauterine exposure should be suspected in children of prepubertal or pubertal ages admitted to hospital with genital abnormalities. Further studies are needed to clarify the effects of endocrine disruptors on the development of the male urogenital system (39).

Table 4. The effects of some specific endocrine disruptors on male urogenital system.

graphic file with name JCRPE-4-51-g4.jpg

The Female Urogenital System

Dioxins:Although not classified as xenoestrogens, dioxins may lead to estrogenic or antiestrogenic effects depending on time of exposure, site (organ) of exposure and presence of estrogen. It has been demonstrated that tumor incidence is increased and latent period of tumor development is decreased in rats exposed to TCDD on the 15th day of gestation and to the chemical carcinogen dimethylbenzanthracene (DMBA) on the 50th day of gestation (40). There have also been studies reporting that fetal TCDD exposure increases breast cancer risk and leads to deterioration in breast tissue morphology (41). Kakeyama et al (42) reported that exposure to low-dose TCDD during the prenatal period led to early activation of the hypothalamic-pituitary-gonadal axis and precocious puberty in rats.

Bisphenol A: Bisphenol A (BPA), which is a xenoestrogen, is a chemical endocrine disruptor frequently encountered in every setting of daily life. While maternal exposure to BPA may indirectly affect the fetus, it may also affect the newborn directly through infant formulas, breast milk and preserved foods (43). In fact, high levels of BPA have been measured in human placental tissue as well as in maternal and fetal plasma at the time of birth (44). Urinary BPA levels measured in children and adolescents have been reported to be higher compared to adults (45). BPA has also been detected in the breast milk of lactating mothers. In the light of these findings, it can be suggested that human fetuses and newborns may readily be exposed to this chemical. Recent studies have reported that food is not the only source of BPA exposure and that parenteral applications may also be a source. BPA half-life in humans is much longer than expected (46). Morphological and developmental abnormalities were noted in the breast tissue of fetuses of mother rats exposed to BPA for 14 days starting from the 8th day of gestation. Mammary duct epithelial cell proliferation in these fetuses was found to be significantly greater compared to that in fetuses whose mothers were not exposed to BPA (47). It has also been observed that intraductal hyperplasias that are defined as preneoplastic lesions may appear in the 3rd postnatal month subsequent to this proliferation and increased ductal branching (48). In another study, 3-4-fold increase in precancerous lesions (intraductal proliferation) during puberty and adulthood has been shown to occur in rats as a result of fetal BPA exposure (49). These results indicate that significant prenatal exposure to BPA leads to persistent changes in breast tissue structure and development, precancerous lesions and carcinoma in situ. Exposure to BPA and other chemicals with estrogen-like effects has been listed as one of the reasons for the increased incidence of breast cancer in modern societies in recent years.

Polychlorinated compounds: Yang et al (50) reported that prenatal exposure to PCBs and PCDFs results in abnormal menstruations and very high FSH and estradiol levels in the follicular phase of the cycle in adolescent girls aged between 13 and 19 years. In a Chinese study, prenatal phthalate exposure (di-n-butyl phthalate (DBP) and di-2-ethylhexyl phthalate (DEHP) was shown to increase the risk of low birth weight (51).

Diethylstilbestrol:Epidemiological studies suggest that exposure to xenoestrogens, such as diethylstilbestrol (DES) and DDT, during the fetal period and during puberty increases the risk of developing cancer. In several studies, it has been reported that intrauterine DES exposure may cause cervical uterine and fallopian tube abnormalities, subfertility, infertility and ectopic pregnancies (52). The effects of certain specific endocrine disruptors on the female urogenital system are presented in Table 5. In newborns with intrauterine growth retardation and in those with sexual differentiation disorders such as hypospadias and undescended testicle, breast milk and maternal serum should be screened for endocrine disruptors and these biological samples should be preserved for further research. Research priority should be given to the identification of early markers and indicators of endocrine disruptors encountered in fetal life (39).

Table 5. The effects of certain specific endocrine disruptors on female urogenital system.

graphic file with name JCRPE-4-51-g5.jpg

Effects of Endocrine Disruptors on Thyroid Function

PCBs:Although PCBs have been prohibited in many countries for years due to their very strongly lipophilic features, they can still be detected in human and animal tissue samples (5,53). PCB, especially their biologically active hydroxylated metabolites, has great structural similarity with thyroxine (T4). In animal studies, it has been shown that intrauterine PCB exposure has negative impact on thyroid hormone levels by leading to a decrease in total T4, free T4 (fT4) and total triiodothyronine (T3) and an increase in thyrotropin (TSH) level and that these effects are dose-dependent (54). There is strong evidence demonstrating reduced thyroid hormone levels in infants whose mothers experienced perinatal exposure to PCB or its hydroxylated metabolites (5,55,56,57). Antibodies against thyroid peroxidase and an increase in thyroid volume have also been noted in the follow-up of infants exposed to PCB (58,59). In another study, PCB levels measured in breast milk have been shown to correlate with low postpartum maternal thyroid hormone levels and high fetal TSH levels at postnatal 2nd-3rd months (54,60).

Dioxins: PCDDs and PCDFs are permanent and very toxic environmental pollutants that are formed as by-products from destruction of several chemical substances, including substances used in pesticide production and for bleaching of cellulose in paper production. These compounds initially diffuse into air, then into soil and then contaminate meat, fish, dairy products and breast milk. When pregnant rats were exposed to PCDD, in male offspring rats, the T4 levels were found to be decreased, while an increase was noted in TSH levels (61). Five-year follow-up revealed a positive correlation between serum thyroid hormone levels and PCDD/PCDF levels in children with prenatal exposure to dioxins (11).

Polybrominated diphenyl ethers: These substances are found in several materials used in daily life including plastic coating of electronic devices such as television and computer, in light bulbs, car spare parts, carpets and bedspreads, dye substances and synthetic textile products. Tetrabromobisphenol A (TBBPA) and polybrominated biphenyls are also classified within the same group as polybrominated diphenyl ethers (PBDE). TBBPA and PBDE show a closer structural similarity with thyroid hormone than PCB (53). Prenatal and postnatal thyroid hormone levels have been found to be low in rats with perinatal exposure to PBDE (62). Even low doses of PBDE have affected thyroid functions; T4 levels of offspring of pregnant rats exposed to PBDE have been found to be decreased at postnatal 3rd week (63).

Pesticides: DDT, hexachlorobenzene (HCB) and nonylphenol are the chemicals whose effects on thyroid functions have been investigated most frequently. Although these substances have been prohibited in many countries, they can be still detected in the environmental cycle as they are still being used in some countries and they have very long half-lives. Evidence regarding the disrupting effects of pesticides on thyroid hormones have been noted in numerous animal and toxicological studies (53).

Perfluorinated chemicals: Owing to their surface protecting features, perfluorinated chemicals (PFCs) are chemicals that are very frequently used in daily life. T4 levels have been found to be decreased in both pregnant rats and their offspring as a result of short- and long-term exposure to these substances (64,65). A transient increase in T4 and a decrease in TSH followed by a decrease in T4 and T3 have been noted following exposure to a single dose of PFC (66).

Phthalates: Phthalates are often impossible to avoid since they are widely present as additives in many plastic products and in several industrial and commercial products. They are found in soft plastic toys, floor coverings, home cleaning products, medical devices, blood bags, cosmetic products and air cleaners. As phthalates are water-soluble, they can reach the fetus via the amniotic fluid in pregnant mothers. Particularly newborns in contact with materials such as catheters and medical tubings in hospitals are exposed to phthalates and they may subsequently develop transient thyroid dysfunction. T3 and T4 levels have been found to be decreased in rats exposed to phthalates in a dose-dependent manner (67). Histopathological changes in the thyroid gland have been noted in some studies (68). Also, a negative correlation has been found between phthalate exposure and total T4 and fT4 levels in pregnant women (69).

BPA: BPA is a chemical that we are easily exposed to because it is found within the structure of many plastic products including food containers, plastic bottles, feeding bottles, and inner parts of cans. T4 levels have been found to be increased at postnatal 15 days in offspring of pregnant rats exposed to BPA (70). However, there have also been studies showing that BPA does not affect thyroid functions (71). Further studies are needed to evaluate the harmful effects of several groups of chemical disruptors on thyroid functions.

Effects of Other Compounds as Endocrine Disruptors

In addition to those mentioned above, effects of other chemical compounds on the endocrine system have also been observed. Children with intrauterine exposure to HCB, a type of chlorine pesticide, were found to have a tendency for obesity when they reach 6 years of age, and they have been shown to have a 2.5-3-fold increased risk of being overweight compared to children not exposed to HCB, independent from diet type and daily activity (72). Testicular dysgenesis syndrome, a clinical entity which comprises testicular cancer, urogenital abnormalities and reduced semen quality, is thought to occur by contact of the fetal testis with endocrine disruptors during intrauterine development (73). Phytoestrogens are abundantly present in our daily food, and a 500 times greater estrogenic effect has been found in infants fed by soy-based formulas as compared to those fed by cow’s milk-based formulas (74). Genistein, found in soy beans, is a weak estrogenic substance which may lead to several pathologies in the reproductive system and also in the thyroid gland through thyroid peroxidase inhibition (75). The effects of intrauterine exposure to endocrine disruptors, which can be detected in umbilical cord blood and meconium samples, are summarized in Table 6.

Table 6. Summary of effects of endocrine disruptors detected in umbilical cord blood and meconium samples (8).

graphic file with name JCRPE-4-51-g6.jpg

CONCLUSION

Endocrine disruptors are commonly found substances that we may encounter in every setting and condition in the modern world and it is virtually impossible to avoid the contact with these chemical compounds in our daily life. Epidemiological and toxicological studies that have been performed over the years and have provided scientific data for the protection of human health and wildlife have shown that nature as a whole is under risk due to these chemicals. These studies also provide evidence to inform local authorities about this threat and about preventive measures to be taken on the issue of endocrine disruptors, particularly with regard to pregnant women and children. These local measures should be considered as an initial step in prevention and global awareness studies should be performed in addition to local studies. Further animal and human studies are also needed to investigate the effects of intrauterine endocrine disruptor exposure on adult health.

References

  • 1.Wang MH, Baskin LS. Endocrine disruptors, genital development, and hypospadias. J Androl. 2008;29:499–505. doi: 10.2164/jandrol.108.004945. [DOI] [PubMed] [Google Scholar]
  • 2.Lee MM. Endocrine Disrupters. A Current Review of Pediatric Endocrinology. 2007:109–118. [Google Scholar]
  • 3.Phillips KP, Foster WG. Key developments in endocrine disrupter research and human health. J Toxicol Environ Health B Crit Rev. 2008;11:322–344. doi: 10.1080/10937400701876194. [DOI] [PubMed] [Google Scholar]
  • 4.Suk WA, Murray K, Avakian MD. Environmental hazards to children's health in the modern world. Mutat Res. 2003;544:235–242. doi: 10.1016/j.mrrev.2003.06.007. [DOI] [PubMed] [Google Scholar]
  • 5.Abaci A, Demir K, Bober E, Buyukgebiz A. Endocrine disrupters - with special emphasis on sexual development. Pediatr Endocrinol Rev. 2009;6:464–475. [PubMed] [Google Scholar]
  • 6.Foster WG, Agzarian J. Toward less confusing terminology in endocrine disruptor research. J Toxicol Environ Health B Crit Rev. 2008;11:152–161. doi: 10.1080/00927870701873214. [DOI] [PubMed] [Google Scholar]
  • 7.7. Whaley DA, Keyes D, Khorrami B. Incorporation of endocrine disruption into chemical hazard scoring for pollution prevention and current list of endocrine disrupting chemicals. Drug Chem Toxicol. 2001;24:359–420. doi: 10.1081/dct-100106265. [DOI] [PubMed] [Google Scholar]
  • 8.Crinnion WJ. Maternal levels of xenobiotics that affect fetal development and childhood health. Altern Med Rev. 2009;14:212–222. [PubMed] [Google Scholar]
  • 9.Bruckner JV. Differences in sensitivity of children and adults to chemical toxicity: the NAS panel report. Regul Toxicol Pharmacol. 2000;31:280–285. doi: 10.1006/rtph.2000.1393. [DOI] [PubMed] [Google Scholar]
  • 10.Barker DJ. The developmental origins of adult disease. Eur J Epidemiol. 2003;18:733–736. doi: 10.1023/a:1025388901248. [DOI] [PubMed] [Google Scholar]
  • 11.Su PH, Chen JY, Chen JW, Wang SL. Growth and thyroid function in children with in utero exposure to dioxin: a 5-year follow-up study. Pediatr Res. 2010;67:205–210. doi: 10.1203/PDR.0b013e3181c8f04b. [DOI] [PubMed] [Google Scholar]
  • 12.Leonardi-Bee J, Smyth A, Britton J, Coleman T. Environmental tobacco smoke and fetal health: systematic review and meta-analysis. Arch Dis Child Fetal Neonatal Ed. 2008;93:351–361. doi: 10.1136/adc.2007.133553. [DOI] [PubMed] [Google Scholar]
  • 13.Choi H, Jedrychowski W, Spengler J, Camann DE, Whyatt RM, Rauh V, et al. International studies of prenatal exposure to polycyclic aromatic hydrocarbons and fetal growth. Environ Health Perspect. 2006;114:1744–1750. doi: 10.1289/ehp.8982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Choi H, Rauh V, Garfinkel R, Tu Y, Perera FP. Prenatal exposure to airborne polycyclic aromatic hydrocarbons and risk of intrauterine growth restriction. Environ Health Perspect. 2008;116:658–665. doi: 10.1289/ehp.10958. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Perera FP, Rauh V, Tsai WY, Kinney P, Camann D, Barr D, Bernert T, Garfinkel R, Tu YH, Diaz D, Dietrich J, Whyatt RM. Effects of transplacental exposure to environmental pollutants on birth outcomes in a multiethnic population. Environ Health Perspect. 2003;111:201–205. doi: 10.1289/ehp.5742. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Sherman JD. Chlorpyrifos (Dursban)-associated birth defects: report of four cases. Arch Environ Health. 1996;51:5–8. doi: 10.1080/00039896.1996.9935986. [DOI] [PubMed] [Google Scholar]
  • 17.Dietert RR, Zelikoff JT. Early-life environment, developmental immunotoxicology, and the risk of pediatric allergic disease including asthma. Birth Defects Res B Dev Reprod Toxicol. 2008;83:547–560. doi: 10.1002/bdrb.20170. [DOI] [PubMed] [Google Scholar]
  • 18.Gogal RM, Holladay SD. Perinatal TCDD exposure and the adult onset of autoimmune disease. J Immunotoxicol. 2008;5:413–418. doi: 10.1080/10408360802483201. [DOI] [PubMed] [Google Scholar]
  • 19.Hertz-Picciotto I, Park HY, Dostal M, Kocan A, Trnovec T, Sram R. Prenatal exposures to persistent and non-persistent organic compounds and effects on immune system development. Basic Clin Pharmacol Toxicol. 2008;102:146–154. doi: 10.1111/j.1742-7843.2007.00190.x. [DOI] [PubMed] [Google Scholar]
  • 20.Dallaire F, Dewailly E, Vezina C, Muckle G, Weber JP, Bruneau S, Ayotte P. Effect of prenatal exposure to polychlorinated biphenyls on incidence of acute respiratory infections in preschool Inuit children. Environ Health Perspect. 2006;114:1301–1305. doi: 10.1289/ehp.8683. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Weisglas-Kuperus N, Patandin S, Berbers GA, Sas TC, Mulder PG, Sauer PJ, Hooijkaas H. Immunologic effects of background exposure to polychlorinated biphenyls and dioxins in Dutch preschool children. Environ Health Perspect. 2000;108:1203–1207. doi: 10.1289/ehp.001081203. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Davidson PW, Strain JJ, Myers GJ, Thurston SW, Bonham MP, Shamlaye CF, Stokes-Riner A, Wallace JM, Robson PJ, Duffy EM, Georger LA, Sloane-Reeves J, Cernichiari E, Canfield RL, Cox C, Huang LS, Janciuras J, Clarkson TW. Neurodevelopmental effects of maternal nutritional status and exposure to methylmercury from eating fish during pregnancy. Neurotoxicology. 2008;29:767–775. doi: 10.1016/j.neuro.2008.06.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Jett DA, Kuhlmann AC, Farmer SJ, Guilarte TR. Age-dependent effects of developmental lead exposure on performance in the Morris water maze. Pharmacol Biochem Behav. 1997;57:271–279. doi: 10.1016/s0091-3057(96)00350-4. [DOI] [PubMed] [Google Scholar]
  • 24.Gomaa A, Hu H, Bellinger D, Schwartz J, Tsaih SW, Gonzalez-Cossio T, Schnaas L, Peterson K, Aro A, Hernandez-Avila M. Maternal bone lead as an independent risk factor for fetal neurotoxicity: a prospective study. Pediatrics. 2002;110:110–118. doi: 10.1542/peds.110.1.110. [DOI] [PubMed] [Google Scholar]
  • 25.Jacobson SW, Fein GG, Jacobson JL, Schwartz PM, Dowler JK. The effect of intrauterine PCB exposure on visual recognition memory. Child Dev. 1985;56:853–860.. [PubMed] [Google Scholar]
  • 26.Chen YC, Yu ML, Rogan WJ, Gladen BC, Hsu CC. A 6-year follow-up of behavior and activity disorders in the Taiwan Yu-cheng children. Am J Public Health. 1994;84:415–421. doi: 10.2105/ajph.84.3.415. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Young JG, Eskenazi B, Gladstone EA, Bradman A, Pedersen L, Johnson C, Barr DB, Furlong CE, Holland NT. Association between in utero organophosphate pesticide exposure and abnormal reflexes in neonates. Neurotoxicology. 2005;26:199–209. doi: 10.1016/j.neuro.2004.10.004. [DOI] [PubMed] [Google Scholar]
  • 28.Jurewicz J, Hanke W. Prenatal and childhood exposure to pesticides and neurobehavioral development: review of epidemiological studies. Int J Occup Med Environ Health. 2008;21:121–132. doi: 10.2478/v10001-008-0014-z. [DOI] [PubMed] [Google Scholar]
  • 29.Norgil D, Main KM, Toppari J, Skakkebaek NE. Impact of exposure to endocrine disrupters in utero and in childhood on adult reproduction. Best Pract Res Clin Endocrinol Metab. 2002;16:289–309. doi: 10.1053/beem.2002.0205. [DOI] [PubMed] [Google Scholar]
  • 30.Toppari J, Kaleva M, Virtanen HE. Trends in the incidence of cryptorchidism and hypospadias, and methodological limitations of registry-based data. Hum Reprod Update. 2001;7:282–286. doi: 10.1093/humupd/7.3.282. [DOI] [PubMed] [Google Scholar]
  • 31.Longnecker MP, Klebanoff MA, Brock JW, Zhou H, Gray KA, Needham LL, Wilcox AJ. Maternal serum level of 1,1-dichloro-2,2-bis(p-chlorophenyl)ethylene and risk of cryptorchidism, hypospadias, and polythelia among male offspring. Am J Epidemiol. 2002;155:313–322. doi: 10.1093/aje/155.4.313. [DOI] [PubMed] [Google Scholar]
  • 32.Bhatia R, Shiau R, Petreas M, Weintraub JM, Farhang L, Eskenazi B. Organochlorine pesticides and male genital anomalies in the child health and development studies. Environ Health Perspect. 2005;113:220–224. doi: 10.1289/ehp.7382. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Pierik FH, Burdorf A, Deddens JA, Juttmann RE, Weber RF. Maternal and paternal risk factors for cryptorchidism and hypospadias: a case-control study in newborn boys. Environ Health Perspect. 2004;112:1570–1576. doi: 10.1289/ehp.7243. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Kakeyama M, Sone H, Miyabara Y, Tohyama C. Perinatal exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin alters activity-dependent expression of BDNF mRNA in the neocortex and male rat sexual behavior in adulthood. Neurotoxicology. 2003;24:207–217. doi: 10.1016/S0161-813X(02)00214-0. [DOI] [PubMed] [Google Scholar]
  • 35.Ikeda M, Mitsui T, Setani K, Tamura M, Kakeyama M, Sone H, Tohyama C, Tomita T. In utero and lactational exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin in rats disrupts brain sexual differentiation. Toxicol Appl Pharmacol. 2005;205:98–105. doi: 10.1016/j.taap.2004.09.010. [DOI] [PubMed] [Google Scholar]
  • 36.Cao Y, Winneke G, Wilhelm M, Wittsiepe J, Lemm F, Furst P, Ranft U, Imohl M, Kraft M, Oesch-Bartlomowicz B, Kramer U. Environmental exposure to dioxins and polychlorinated biphenyls reduce levels of gonadal hormones in newborns: results from the Duisburg cohort study. Int J Hyg Environ Health. 2008;211:30–39. doi: 10.1016/j.ijheh.2007.04.005. [DOI] [PubMed] [Google Scholar]
  • 37.Hsu PC, Lai TJ, Guo NW, Lambert GH, Leon Guo Y. Serum hormones in boys prenatally exposed to polychlorinated biphenyls and dibenzofurans. J Toxicol Environ Health A. 2005;68:1447–1456. doi: 10.1080/15287390590967360. [DOI] [PubMed] [Google Scholar]
  • 38.Gonc N. Endokrin Bozucular. Katkı Pediatri Dergisi. 2008;30:511–518. [Google Scholar]
  • 39.Diamanti-Kandarakis E, Bourguignon JP, Giudice LC, Hauser R, Prins GS, Soto AM, Zoeller RT, Gore AC. Endocrine-disrupting chemicals: an Endocrine Society scientific statement. Endocr Rev. 2009;30:293–342. doi: 10.1210/er.2009-0002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Brown NM, Manzolillo PA, Zhang JX, Wang J, Lamartiniere CA. Prenatal TCDD and predisposition to mammary cancer in the rat. Carcinogenesis. 1998;19(9):1623–9. doi: 10.1093/carcin/19.9.1623. [DOI] [PubMed] [Google Scholar]
  • 41.Fenton SE. Endocrine-disrupting compounds and mammary gland development: early exposure and later life consequences. Endocrinology. 2006;147:18–24. doi: 10.1210/en.2005-1131. [DOI] [PubMed] [Google Scholar]
  • 42.Kakeyama M, Sone H, Tohyama C. Perinatal exposure of female rats to 2,3,7,8-tetrachlorodibenzo-p-dioxin induces central precocious puberty in the offspring. J Endocrinol. 2008;197:351–358. doi: 10.1677/JOE-08-0062. [DOI] [PubMed] [Google Scholar]
  • 43.vom Saal FS, Akingbemi BT, Belcher SM, Birnbaum LS, Crain DA, Eriksen M, Farabollini F, Guillette LJ Jr, Hauser R, Heindel JJ, Ho SM, Hunt PA, Iguchi T, Jobling S, Kanno J, Keri RA, Knudsen KE, Laufer H, LeBlanc GA, Marcus M, McLachlan JA, Myers JP, Nadal A, Newbold RR, Olea N, Prins GS, Richter CA, Rubin BS, Sonnenschein C, Soto AM, Talsness CE, Vandenbergh JG, Vandenberg LN, Walser-Kuntz DR, Watson CS, Welshons WV, Wetherill Y, Zoeller RT. Chapel Hill bisphenol A expert panel consensus statement: integration of mechanisms, effects in animals and potential to impact human health at current levels of exposure. Reprod Toxicol. 2007;24:131–138. doi: 10.1016/j.reprotox.2007.07.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Vandenberg LN, Hauser R, Marcus M, Olea N, Welshons WV. Human exposure to bisphenol A (BPA) Reprod Toxicol. 2007;24:139–177. doi: 10.1016/j.reprotox.2007.07.010. [DOI] [PubMed] [Google Scholar]
  • 45.Calafat AM, Weuve J, Ye X, Jia LT, Hu H, Ringer S, Huttner K, Hauser R. Exposure to bisphenol A and other phenols in neonatal intensive care unit premature infants. Environ Health Perspect. 2009;117:639–644. doi: 10.1289/ehp.0800265. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Calafat AM, Weuve J, Ye X, Jia LT, Hu H, Ringer S, Huttner K, Hauser R. Exposure to bisphenol A and other phenols in neonatal intensive care unit premature infants. Environ Health Perspect. 2009;117:639–644. doi: 10.1289/ehp.0800265. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Stahlhut RW, Welshons WV, Swan SH. Bisphenol A data in NHANES suggest longer than expected half-life, substantial nonfood exposure, or both. Environ Health Perspect. 2009;117:784–789.. doi: 10.1289/ehp.0800376. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Vandenberg LN, Maffini MV, Wadia PR, Sonnenschein C, Rubin BS, Soto AM. Exposure to environmentally relevant doses of the xenoestrogen bisphenol-A alters development of the fetal mouse mammary gland. Endocrinology. 2007;148:116–127. doi: 10.1210/en.2006-0561. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Vandenberg LN, Maffini MV, Schaeberle CM, Ucci AA, Sonnenschein C, Rubin BS, Soto AM. Perinatal exposure to the xenoestrogen bisphenol-A induces mammary intraductal hyperplasias in adult CD-1 mice. Reprod Toxicol. 2008;26:210–219. doi: 10.1016/j.reprotox.2008.09.015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Jenkins S, Raghuraman N, Eltoum I, Carpenter M, Russo J, Lamartiniere CA. Oral exposure to bisphenol a increases dimethylbenzanthracene-induced mammary cancer in rats. Environ Health Perspect. 2009;117:910–915. doi: 10.1289/ehp.11751. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Yang CY, Yu ML, Guo HR, Lai TJ, Hsu CC, Lambert G, Guo YL. The endocrine and reproductive function of the female Yucheng adolescents prenatally exposed to PCBs/PCDFs. Chemosphere. 2005;61:355–360. doi: 10.1016/j.chemosphere.2005.02.089. [DOI] [PubMed] [Google Scholar]
  • 52.Zhang Y, Lin L, Cao Y, Chen B, Zheng L, Ge RS. Phthalate levels and low birth weight: a nested case-control study of Chinese newborns. J Pediatr. 2009;155:500–544. doi: 10.1016/j.jpeds.2009.04.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Newbold R. Cellular and molecular effects of developmental exposure to diethylstilbestrol: implications for other environmental estrogens. Environ Health Perspect. 1995;103:83–87. doi: 10.1289/ehp.95103s783. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Boas M, Main KM, Feldt-Rasmussen U. Environmental chemicals and thyroid function: an update. Curr Opin Endocrinol Diabetes Obes. 2009;16:385–391. doi: 10.1097/MED.0b013e3283305af7. [DOI] [PubMed] [Google Scholar]
  • 55.Chevrier J, Eskenazi B, Bradman A, Fenster L, Barr DB. Associations between prenatal exposure to polychlorinated biphenyls and neonatal thyroid-stimulating hormone levels in a Mexican-American population, Salinas Valley, California. Environ Health Perspect. 2007;115:1490–1496. doi: 10.1289/ehp.9843. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Meerts IA, Assink Y, Cenijn PH, Weijers BM, Bergman A, Koeman JH, Brouwer A. Placental transfer of a hydroxylated polychlorinated biphenyl and effects on fetal and maternal thyroid hormone homeostasis in the rat. Toxicol Sci. 2002;68:361–371. doi: 10.1093/toxsci/68.2.361. [DOI] [PubMed] [Google Scholar]
  • 57.Crofton KM, Kodavanti PR, rr-Yellin EC, Casey AC, Kehn LS. PCBs, thyroid hormones, and ototoxicity in rats: cross-fostering experiments demonstrate the impact of postnatal lactation exposure. Toxicol Sci. 2000;57:131–140. doi: 10.1093/toxsci/57.1.131. [DOI] [PubMed] [Google Scholar]
  • 58.Darnerud PO, Morse D, Klasson-Wehler E, Brouwer A. Binding of a 3,3', 4,4'-tetrachlorobiphenyl (CB-77) metabolite to fetal transthyretin and effects on fetal thyroid hormone levels in mice. Toxicology. 1996;106:105–114. doi: 10.1016/0300-483x(95)03169-g. [DOI] [PubMed] [Google Scholar]
  • 59.Langer P, Tajtakova M, Kocan A, Petrik J, Koska J, Ksinantova L, Radikova Z, Ukropec J, Imrich R, Huckova M, Chovancova J, Drobna B, Jursa S, Vlcek M, Bergman A, Athanasiadou M, Hovander L, Shishiba Y, Trnovec T, Sebokova E, Klimes I. Thyroid ultrasound volume, structure and function after long-term high exposure of large population to polychlorinated biphenyls, pesticides and dioxin. Chemosphere. 2007;69:118–127. doi: 10.1016/j.chemosphere.2007.04.039. [DOI] [PubMed] [Google Scholar]
  • 60.Schell LM, Gallo MV, Ravenscroft J, DeCaprio AP. Persistent organic pollutants and anti-thyroid peroxidase levels in Akwesasne Mohawk young adults. Environ Res. 2009;109:86–92. doi: 10.1016/j.envres.2008.08.015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Koopman-Esseboom C, Morse DC, Weisglas-Kuperus N, Lutkeschipholt IJ, Tuinstra LG, Brouwer A, Sauer PJ. Effects of dioxins and polychlorinated biphenyls on thyroid hormone status of pregnant women and their infants. Pediatr Res. 1994;36:468–473. doi: 10.1203/00006450-199410000-00009. [DOI] [PubMed] [Google Scholar]
  • 62.Zhou T, Taylor MM, DeVito MJ, Crofton KM. Developmental exposure to brominated diphenyl ethers results in thyroid hormone disruption. Toxicol Sci. 2002;66:105–116. doi: 10.1093/toxsci/66.1.105. [DOI] [PubMed] [Google Scholar]
  • 63.Kuriyama SN, Wanner A, Fidalgo-Neto AA, Talsness CE, Koerner W, Chahoud I. Developmental exposure to low-dose PBDE-99: tissue distribution and thyroid hormone levels. Toxicology. 2007;242:80–90. doi: 10.1016/j.tox.2007.09.011. [DOI] [PubMed] [Google Scholar]
  • 64.Thibodeaux JR, Hanson RG, Rogers JM, Grey BE, Barbee BD, Richards JH, Butenhoff JL, Stevenson LA, Lau C. Exposure to perfluorooctane sulfonate during pregnancy in rat and mouse. I: maternal and prenatal evaluations. Toxicol Sci. 2003;74:369–781. doi: 10.1093/toxsci/kfg121. [DOI] [PubMed] [Google Scholar]
  • 65.Lau C, Thibodeaux JR, Hanson RG, Rogers JM, Grey BE, Stanton ME, Butenhoff JL, Stevenson LA. Exposure to perfluorooctane sulfonate during pregnancy in rat and mouse. II: postnatal evaluation. Toxicol Sci. 2003;74:382–392. doi: 10.1093/toxsci/kfg122. [DOI] [PubMed] [Google Scholar]
  • 66.Chang SC, Thibodeaux JR, Eastvold ML, Ehresman DJ, Bjork JA, Froehlich JW, Lau C, Singh RJ, Wallace KB, Butenhoff JL. Thyroid hormone status and pituitary function in adult rats given oral doses of perfluorooctanesulfonate (PFOS) Toxicology. 2008;243:330–339. doi: 10.1016/j.tox.2007.10.014. [DOI] [PubMed] [Google Scholar]
  • 67.O'Connor JC, Frame SR, Ladics GS. Evaluation of a 15-day screening assay using intact male rats for identifying antiandrogens. Toxicol Sci. 2002;69:92–108. doi: 10.1093/toxsci/69.1.92. [DOI] [PubMed] [Google Scholar]
  • 68.Howarth JA, Price SC, Dobrota M, Kentish PA, Hinton RH. Effects on male rats of di-(2-ethylhexyl) phthalate and di-n-hexylphthalate administered alone or in combination. Toxicol Lett. 2001;12:35–43. doi: 10.1016/s0378-4274(01)00313-7. [DOI] [PubMed] [Google Scholar]
  • 69.Huang PC, Kuo PL, Guo YL, Liao PC, Lee CC. Associations between urinary phthalate monoesters and thyroid hormones in pregnant women. Hum Reprod. 2007;22:2715–2722. doi: 10.1093/humrep/dem205. [DOI] [PubMed] [Google Scholar]
  • 70.Zoeller RT, Bansal R, Parris C. Bisphenol-A, an environmental contaminant that acts as a thyroid hormone receptor antagonist in vitro, increases serum thyroxine, and alters RC3/neurogranin expression in the developing rat brain. Endocrinology. 2005;146:607–612. doi: 10.1210/en.2004-1018. [DOI] [PubMed] [Google Scholar]
  • 71.Xu X, Liu Y, Sadamatsu M, Tsutsumi S, Akaike M, Ushijima H, Kato N. Perinatal bisphenol A affects the behavior and SRC-1 expression of male pups but does not influence on the thyroid hormone receptors and its responsive gene. Neurosci Res. 2007;58:149–155. doi: 10.1016/j.neures.2007.02.011. [DOI] [PubMed] [Google Scholar]
  • 72.Smink A, Ribas-Fito N, Garcia R, Torrent M, Mendez MA, Grimalt JO, et al. Exposure to hexachlorobenzene during pregnancy increases the risk of overweight in children aged 6 years. Acta Paediatr. 2008;97:1465–1469. doi: 10.1111/j.1651-2227.2008.00937.x. [DOI] [PubMed] [Google Scholar]
  • 73.Bay K, Asklund C, Skakkebaek NE, Andersson AM. Testicular dysgenesis syndrome: possible role of endocrine disrupters. Best Pract Res Clin Endocrinol Metab. 2006;20:77–90. doi: 10.1016/j.beem.2005.09.004. [DOI] [PubMed] [Google Scholar]
  • 74.Cao Y, Calafat AM, Doerge DR, Umbach DM, Bernbaum JC, Twaddle NC, Ye X, Rogan WJ. Isoflavones in urine, saliva, and blood of infants: data from a pilot study on the estrogenic activity of soy formula. J Expo Sci Environ Epidemiol. 2009;19:223–234. doi: 10.1038/jes.2008.44. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 75.Divi RL, Chang HC, Doerge DR. Anti-thyroid isoflavones from soybean: isolation, characterization, and mechanisms of action. Biochem Pharmacol. 1997;54:1087–1096. doi: 10.1016/s0006-2952(97)00301-8. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Research in Pediatric Endocrinology are provided here courtesy of Galenos Yayinevi

RESOURCES